SCHEMBL19909528

SCHEMBL19909528

Cc1cc(-c2cc(-n3c4ccccc4c4ccc(-c5ccccc5)cc43)c(C#N)cc2-n2c3ccccc3c3ccc(-c4ccccc4)cc32)cc(C)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HIF1A Q16665 1/20 0.38
ALDH1A1 P00352 5/20 0.37
HPGD P15428 4/20 0.37
KDM4E B2RXH2 3/20 0.37
MAPK1 P28482 2/20 0.37
HSD17B10 Q99714 2/20 0.37
GLA P06280 1/20 0.37
LMNA P02545 1/20 0.36
ABCG2 Q9UNQ0 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19909514 0.98 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19NPSR1SMN1; SMN2
SCHEMBL19913237 0.94 MAOA (0.34) CYP1A2CYP2C9CYP2C19NPSR1SMN1; SMN2
SCHEMBL22170441 0.94 CHEK1 (0.37) CYP1A2CYP2C9CYP2C19NPSR1ABCG2
SCHEMBL19913212 0.93 CYP1A2 (0.38) CYP1A2CYP2C9CYP2C19NPSR1SMN1; SMN2
SCHEMBL19913231 0.93 AR (0.38) CYP1A2CYP2C9CYP2C19NPSR1SMN1; SMN2
SCHEMBL19913263 0.93 ABCG2 (0.38) CYP1A2CYP2C9CYP2C19NPSR1SMN1; SMN2
SCHEMBL19919714 0.92 ADORA2A (0.37) CYP1A2CYP2C9CYP2C19SMN1; SMN2HIF1A
SCHEMBL19913242 0.91 GRIN1 (0.33) CYP1A2CYP2C9CYP2C19NPSR1SMN1; SMN2
SCHEMBL19909094 0.90 IRAK4 (0.32) CYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL23487723 0.90 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19NPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287451-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 CYP1A2 344/4885CYP2C9 102/4885CYP2C19 145/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 CYP1A2 2290/4885CYP2C9 1631/4885CYP2C19 2242/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 CYP1A2 344/4885CYP2C9 102/4885CYP2C19 145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.